Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Oppenheimer Asset Management
Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Oppenheimer Asset Management
from 13F filings
Historical chart of Oppenheimer Asset Management investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Oppenheimer Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Oppenheimer Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $136k | 83k | 1.64 |
| 2025-06-30 | $103k | 79k | 1.30 |
| 2025-03-31 | $91k | 79k | 1.15 |
| 2024-12-31 | $83k | 78k | 1.06 |
| 2024-09-30 | $99k | 85k | 1.17 |
More positions owned by Oppenheimer Asset Management
View all positions for Oppenheimer Asset Management
Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1
View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1